Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Intermittent OSI-906 Dosing

This study has been completed.
Information provided by (Responsible Party):
Astellas Pharma Inc Identifier:
First received: August 7, 2007
Last updated: September 12, 2011
Last verified: September 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)